Suppr超能文献

停止 GnRH 激动剂/拮抗剂方案:对 IVF 中卵巢刺激的不同看法。

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF.

机构信息

Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat Gan, Israel.

Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv-Yafo, Israel.

出版信息

Reprod Biol Endocrinol. 2023 Jan 30;21(1):13. doi: 10.1186/s12958-023-01069-7.

Abstract

Ovarian stimulation (OS) is one of the key factors in the success of in vitro fertilization-embryo transfer (IVF-ET), by enabling the recruitment of numerous healthy fertilizable oocytes and, thereby, multiple embryos. The Stop GnRH-agonist/GnRH-antagonist (GnRH-ag/GnRH-ant), which offers all the advantages of using long suppressive GnRH-ag, with GnRH-ant, is in my opinion a valuable addition to the armamentarium of OS protocols. It allows cycle programming, better follicular synchronization and offers successful outcome in a variety of challenging cases such as poor responders, Poseidon group 4 poor prognosis patients, those with elevated peak progesterone (P) serum levels, poor embryo quality or repeated IVF failures.

摘要

卵巢刺激(OS)是体外受精-胚胎移植(IVF-ET)成功的关键因素之一,它可以募集大量健康的可受精卵子,并由此产生多个胚胎。我认为,使用长效抑制 GnRH-激动剂(GnRH-ag)联合 GnRH 拮抗剂(GnRH-ant)的 Stop GnRH-agonist/GnRH-antagonist(GnRH-ag/GnRH-ant)是 OS 方案中的一种有价值的补充,它具有 GnRH-ag 的所有优势,能够进行周期编程,更好地同步卵泡,并在各种具有挑战性的情况下取得成功,如卵巢反应不良、Poseidon 分组 4 预后不良的患者、血清孕激素(P)峰值升高、胚胎质量差或反复 IVF 失败的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a16f/9885692/018dd32351b0/12958_2023_1069_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验